Available via license: CC BY-NC 3.0
Content may be subject to copyright.
ISSN 2234-3806 • eISSN 2234-3814
359
http://dx.doi.org/10.3343/alm.2012.32.5.359
www.annlabmed.org
Ann Lab Med 2012;32:359-361
http://dx.doi.org/10.3343/alm.2012.32.5.359
Brief Communication
Clinical Microbiology
Multiplex PCR for Rapid Detection of Genes Encoding
Class A Carbapenemases
Sang Sook Hong, M.D.
1
, Kyeongmi Kim, M.D.
1
, Ji Young Huh, M.D.
1
, Bochan Jung, M.D.
2
, Myung Seo Kang, M.D.
1
,
and Seong Geun Hong, M.D.
1
Department of Laboratory Medicine
1
, CHA Bundang Medical Center, CHA University, Seongnam; Department of Laboratory Medicine
2
, CHA Gumi Medical
Center, CHA University, Gumi, Korea
In recent years, there have been increasing reports of KPC-producing
Klebsiella pneu-
moniae
in Korea. The modied Hodge test can be used as a phenotypic screening test for
class A carbapenamase (CAC)-producing clinical isolates; however, it does not distinguish
between carbapenemase types. The conrmation of type of CAC is important to ensure
optimal therapy and to
prevent transmission. This study applied a novel multiplex PCR as-
say to detect and differentiate CAC genes in a single reaction. Four primer pairs were de-
signed to amplify fragments encoding
4 CAC families (SME, IMI/NMC-A, KPC, and GES).
The multiplex PCR detected all genes tested for
4 CAC families that could be differentiated
by fragment size according to gene type. This multiplex PCR offers
a simple and useful
approach for detecting and distinguishing CAC genes in carbapenem-resistant strains that
are metallo-
β
-lactamase nonproducers.
Key Words:
Carbapenemase, Multiplex PCR, KPC, GES
Received: January 26, 2012
Revision received: May 21, 2012
Accepted: July 9, 2012
Corresponding author: Seong Geun Hong
Department of Laboratory Medicine, CHA
Bundang Medical Center, CHA University,
59 Yatap-ro, Bundang-gu, Seongnam
463-712, Korea
Tel: +82-31-780-5463
Fax: +82-31-780-5476
E-mail: hlseo@cha.ac.kr
© The Korean Society for Laboratory Medicine.
This is an Open Access article distributed under
the terms of the Creative Commons Attribution
Non-Commercial License (http://creativecom-
mons.org/licenses/by-nc/3.0) which permits
unrestricted non-commercial use, distribution,
and reproduction in any medium, provided the
original work is properly cited.
Carbapenems are important antibiotics for the treatment of in-
fections caused by multidrug-resistant gram-negative bacilli [
1,
2]; however, carbapenem-resistance is increasing, causing in-
fections that are difcult to treat [
2-4]. Bacterial production of
carbapenemases is one of the most important mechanisms of
carbapenem resistance [
1]. There are 3 molecular classes of
carbapenemases: A (penicill
inases); B (metallo-
β
-lactamases,
MBLs); and D (oxacillinases). The class A carbapenemases
(CACs) include the SME, IMI/NMC-A, SFC, BIC, KPC, and some
type of GES family proteins. The genes for the SME, IMI/NMC-A
(except IMI-
2), SFC, and BIC enzymes are chromosomal, and
the genes for KPC and GES are carried on plasmids [
1]. KPC
producers have caused severe treatment problems in hospitals
around New
York and have also been reported in Europe, South
America, and China [
5-8]. In Korea, KPC-producing
Klebsiella
pneumoniae
have rarely been detected. However, several cases
were reported in
2010 and 2011 (Interscience Conference on
Antimicrobial Agents and Chemotherapy
2011 poster c2-652,
unpublished observation) [
9, 10].
The modied Hodge test (MHT) can be used as a phenotypic
conrmatory test f
or suspected carbapenemase production in
Enterobacteriaceae
[11]. However, it is reported that the MHT
shows approximately
25% false positive results among carbap-
enemase nonproducers, mainly AmpC hyperproducers and
strains harboring CTX-M [
12]. Moreover, it does not distinguish
between carbapenemase types or CAC types.
The major concern from the therapeutic and epidemiologic
perspective is with
transmissible and not chromosomal carbap-
enemases [
1, 2], and this information cannot be acquired by
the phenotypic methods. Conrmation of the CAC type is impor-
tant to ensure optimal therapy and to prevent transmission [
3].
In this study, we developed a multiplex PCR assay to detect and
differentiate multiple CAC genes in a single reaction.
Eleven CAC producers (1 SME-producing
Serratia marce-
Hong SS, et al.
Multiplex PCR for class A carbapenemases
360
www.annlabmed.org
http://dx.doi.org/10.3343/alm.2012.32.5.359
scens
, 2 IMI/NMC-A-producing
Enterobacter cloacae
, 2 KPC-
producing
Enterobacteriaceae
, and 6 GES-producing
Klebsiella
pneumoniae
); 7 MBL producers (3 VIM-producing
Pseudomo-
nas aeruginosa
, 2 IMP-producing
P. aeruginosa
, 1 IMP-produc-
ing
Acinetobacter baumannii
, and 1 SIM-producing
A. bauman-
nii
); and 5 non-carbapenemase-producing
Enterobacteriaceae
were studied (Table
1).
The bacterial cells
were lysed by heating at 95
°
C for 10 min,
and cellular debris was removed by centrifugation at
13,000 rpm
for
5 min. The supernatant was used as the source of amplica-
tion templates. PCR was performed with a nal volume of
20
μ
L
in
0.2 mL thin-walled tubes (Accupower
TM
HotStart PCR PreMix;
Bioneer, Daejeon, Korea).
We designed
4 primer pairs for 4 CAC families (SME, IMI/NMC-
A, KPC, and GES). The
genes encoding IMI and NMC-A type
CACs are similar to each other and could not be differentiated by
conventional PCR. Therefore, a single primer pair for the detection
of these
2 CAC families was designed. The SFC-1 and the BIC-1
enzymes have been found in environmental isolates, and the cor-
responding genes are chromosomally encoded [
13, 14]. For this
reason, we did not design pairs of primers fo
r these genes. The
primers used in this study were GES primers for
bla
GES1-9
and
bla
GES11-20
(GES-F: 5
’
-GCTTCATTCACGCACTATT-3
’
; GES-MR:
5
’
-CGATGCTAGAAACCGCTC-3
’
; product size: 323 bp), IMI/NMC-
A primers for
bla
IMI1-3
and
bla
NMC-A
(IMI(NMC)-F1: 5
’
-TGCGGTC-
GATTGGAGATAAA-
3
’
; IMI(NMC)-R1: 5
’
-CGATTCTTGAAGCTTCT-
GCG-
3
’
; product size: 399 bp), SME primers for
bla
SME1-3
(SME-F1:
5
’
-ACTTTGATGGGAGGATTGGC-3
’
; SME-R1: 5
’
-ACGAATTCGAG-
CATCACCAG-
3
’
; product size: 551 bp), and KPC primers for
bla
KPC2-13
(KPCF2: 5
’
-GTATCGCCGTCTAGTTCTGC-3
’
; KPCFR:
5
’
-GGTCGTGTTTCCCTTTAGCC-3
’
; product size 638 bp). The PCR
program consisted of an initial denaturation step at
94
°
C for 5 min,
followed by
25 cycles of DNA denaturation at 94
°
C for 30 sec,
primer annealing at
50
°
C for 30 sec, and primer extension at 72
°
C
for
1 min. After the last cycle, a nal extension step at 72
°
C for 7
min was added.
The GenBank nucleotide sequence accession numbers for
the sequences studied here were as follows: GES-
1 (AF156486);
GES-
2 (AF326355); GES-3 (AB113580); GES-4 (AB116260); GES-5
(AY
494717); GES-6 (AY494718); GES-7 (IBC-1, AF208529); GES-8
(IBC-
2, AF329699); GES-9 (AY920928); GES-11 (FJ854362); GES-
12 (FN554543); GES-13 (GU169702); GES-14 (GU207844); GES-
15 (GU208678); GES-16 (HM173356); GES-17 (HQ874631); GES-
18 (JQ028729); GES-19 (JN596280); GES-20 (JN596280); IMI-1
(U
50278); IMI-2 (DQ173429); IMI-3 (GU015024); NMC-A (Z21956);
SME-
1 (Z28968); SME-2 (AF275256); SME-3 (AY584237); KPC-2
(AY
034847); KPC-3 (AF395881); KPC-4 (AY700571); KPC-5
(EU
400222); KPC-6 (EU555534); KPC-7 (EU729727); KPC-8
(FJ
234412); KPC-9 (FJ624872); KPC-10 (GQ140348); KPC-11
(HM
066995); KPC-12 (HQ342889); and KPC-13 (HQ342890).
The CAC families could be differentiated into
4 groups, SME,
IMI/NMC-A, KPC, and GES, by the PCR product size (Fig.
1).
None of the non-CAC producers included in this study produced
PCR product bands. Not all genotypes of CAC were tested: only
SME-
1, IMI-1, NMC-A, KPC-2, KPC-3, and GES-5-type enzyme-
producing strain
s were included in this study. The primers for
the genotypic detection of SME, KPC and GES enzymes were
exactly complementary to the corresponding GenBank sequences,
but the primers for IMI/NMC-A were not complementary at
1
base each in the forward and reverse sequences of IMI-
3 and
NMC-A. Therefore, it is somewhat uncertain whether this multi-
plex PCR assay would be able to detect all of the geno
types of
CACs described above.
Table 1. Bacterial strains used for class A carbapenemase multiplex
PCR
Enzyme family
N of
strains
Strain
Enzyme
type*
Source
†
Class A carbapenemase
SME 1
Serratia marcescens
SME-1 CRAB
IMI 1
Enterobacter cloacae
IMI-1 CRAB
NMC-A 1
Enterobacter cloacae
NMC-A CRAB
KPC 1
Klebsiella pneumoniae
KPC-2 CRAB
1
Escherichia coli
KPC-3 CRAB
GES 6
Klebsiella pneumoniae
GES-5 like Our laboratory
Metallo-ß-lactamase
VIM 3
Pseudomonas aeruginosa
VIM-2 like Our laboratory
IMP 2
Pseudomonas aeruginosa
IMP-6 like Our laboratory
1
Acinetobacter baumannii
IMP-25 like Our laboratory
SIM 1
Acinetobacter baumannii
SIM-1 like Our laboratory
Non-carbapenemase
ESBL 1
Escherichia coli
TEM type Our laboratory
1
Escherichia coli
SHV type Our laboratory
1
Klebsiella pneumoniae
SHV type Our laboratory
1
Citrobacter freundii
TEM type Our laboratory
ESBL+AmpC
(EBC
‡
)
1
Klebsiella pneumoniae
SHV type Our laboratory
*ESBLs were detected by CLSI phenotypic conrmatory tests and type spe-
cic PCR;
†
CRAB, Center for Research in Anti-Infectives and Biotechnology,
Department of Medical Microbiology and Immunology, School of Medicine,
Creighton University, Omaha, Nebraska;
‡
EBC is a group of AmpC
β
-lactamase
originated from
E. cloacae
.
Abbreviation: ESBL, extended-spectrum
β
-lactamase.
Hong SS, et al.
Multiplex PCR for class A carbapenemases
361
http://dx.doi.org/10.3343/alm.2012.32.5.359
www.annlabmed.org
In summary, this multiplex PCR method appears to be a sim-
ple and useful approach for detecting and distinguishing CAC
genes in MBL-negative carbapenem-resistant strains. Therefore,
this method should be helpful for characterization of CACs and
prevention of the spread of pathogens producing these enzymes.
Authors’ Disclosures of Potential Conicts of
Interest
No potential conicts of interest relevant to this article were re-
ported.
Acknowledgement
We thank Dr. Kenneth S. Thomson (Center for Research in Anti-
Infectives and Biotechnology, Department of Medical Microbiol-
ogy and Immunology, School of Medicine, Creighton University,
Omaha, Nebraska) for providing class A carbapenemase-pro-
ducing isolates.
REFERENCES
1. Patel G and Bonomo RA. Status report on carbapenemases: challenges
and prospects. Expert Rev Anti Infect Ther 2011;9:555-70.
2. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant
En-
terobacteriaceae:
epidemiology and prevention. Clin Infect Dis 2011;53:
60-7.
3. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M,
et al. Acquired carbapenemases in Gram-negative bacterial pathogens:
detection and surveillance issues. Clin Microbiol Infect 2010;16:112-22.
4. Cornaglia G and Rossolini GM. The emerging threat of acquired car-
bapenemases in Gram-negative bacteria. Clin Microbiol Infect 2010;16:
99-101.
5. Ambretti S, Gaibani P, Caroli F, Miragliotta L, Sambri V. A carbapenem-
resistant
Klebsiella pneumoniae
isolate harboring KPC-1 from Italy. New
Microbiol 2010;33:281-2.
6. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. First
identication of
Pseudomonas aeruginosa
isolates producing a KPC-type
carbapenem-hydrolyzing
β
-lactamase. Antimicrob Agents Chemother
2007;51:1553-5.
7. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-
2 in a
Klebsiella pneumoniae
isolate from China. Antimicrob Agents
Chemother 2007;51:763-5.
8. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW,
Steward CD, et al. Novel carbapenem-hydrolyzing
β
-lactamase, KPC-1,
from a carbapenem-resistant strain of
Klebsiella pneumoniae
. Antimi-
crob Agents Chemother 2001;45:1151-61.
9. Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, et al. KPC-pro-
ducing extreme drug-resistant
Klebsiella pneumoniae
isolate from a pa-
tient with diabetes mellitus and chronic renal failure on hemodialysis in
South Korea. Antimicrob Agents Chemother 2010;54:2278-9.
10. Roh KH, Lee CK, Sohn JW, Song W, Yong D, Lee K. Isolation of a
Kleb-
siella pneumoniae
isolate of sequence type 258 producing KPC-2 car-
bapenemase in Korea. Korean J Lab Med 2011;31:298-301.
11. Thomson KS. Extended-Spectrum-
β
-Lactamase, AmpC, and Carbapen-
emase issues. J Clin Microbiol 2010;48:1019-25.
12. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. Sensitive
screening tests for suspected class A carbapenemase production in
species of
Enterobacteriaceae
. J Clin Microbiol 2009;47:1631-9.
13. Girlich D, Poirel L, Nordmann P. Novel ambler class A carbapenem-hy-
drolyzing
β
-lactamase from a
Pseudomonas fluorescens
isolate from
the Seine River, Paris, France. Antimicrob Agents Chemother 2010;54:
328-32.
14. Henriques I, Moura A, Alves A, Saavedra MJ, Correia A. Molecular
characterization of a carbapenem-hydrolyzing class A
β
-lactamase,
SFC-1, from
Serratia fonticola
UTAD54. Antimicrob Agents Chemother
2004;48:2321-4.
700 bp
500 bp
400 bp
300 bp
200 bp
100 bp
KPC
SME
IMI/NMC-A
GES
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Fig. 1. Results of multiplex PCR for class A carbapenemase (CAC)-
producing strains. Multiplex PCR products were separated on a 2%
agarose gel. Lanes 1 and 14 show the 100-bp DNA ladder; lane 2,
the PCR product of the negative control (distilled water); lanes 3
and 4, KPC-type enzyme-producing strains; lane 5, SME-type; lanes
6 and 7, NMC-A and IMI-type, respectively; lanes 8-13, GES-type.
The amplied product from each PCR is indicated on the right, and
the size of the marker in base pairs is shown on the left.